PaulA.SievingMDPhD

Retinal Disease

Professor of Ophthalmology, UC Davis

Dr. Sieving is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
UC Davis Eye Care Sacramento, CA. 95817
4860 Y. Street. Suite 2400
Sacramento, CA 95817

Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1984 - 1985
University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 1978 - 1982
University of Illinois College of MedicineClass of 1978

Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis Start of enrollment: 2003 May 19
Active, not recruiting
CNTF Implants for CNGB3 Achromatopsia Start of enrollment: 2012 Jul 01
Completed
Phase 1, Phase 2

PubMed

116 citations
Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy.
Paul A. Sieving, Prem Chaudhry, Mineo Kondo, Matthew Provenzano, David M. Wu
Proceedings of the National Academy of Sciences of the United States of America. 2001-02-13
171 citations
Biology and therapy of inherited retinal degenerative disease: insights from mouse models.
Shobi Veleri, Csilla H. Lazar, Bo Chang, Paul A. Sieving, Eyal Banin
Disease Models & Mechanisms. 2015-02-01
353 citations
A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy
Kang Zhang, Marina Kniazeva, Min Han, Wen Li, Zhengya Yu
Nature Genetics. 2001-01-01

Journal Articles

Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity
Emily Y Chew, Catherine Cukras, Paul A Sieving, Investigative Ophthalmology and Visual Science

Biotherapies: The Next Frontier in Vision MedicineApril 28th, 2023
UC President Michael Drake on Campus to Help Induct Eye Center ChairholderSeptember 20th, 2021
MIL-OSI USA: Report: Dry AMD Requires Broad, Systems Biology Approach Leveraging Big Data, Multiple DisciplinesJuly 27th, 2019
Join now to see all

Preclinical And Clinical Development Of Treatment For X-Linked RetinoschisisNational Institute On Deafness And Other Communication Disorders2009–2011
Pathophysiology And Treatment Of Retinal Degenerations In Animal ModelsNational Institute On Deafness And Other Communication Disorders2009–2011
Mechanisms And Treatment Of Retinal Degeneration In Animal Models And HumansNational Institute On Deafness And Other Communication Disorders2008
Retinoschisis--Genetic Linkage And Positional CloningNational Center For Research Resources1997–2002
Inner Retinal Contributions To The ERGNational Eye Institute1986–2001
Juvenile RetinoschisisNational Eye Institute1997–2000
Retinoschisis--Genetic Linkage And Postional CloningNational Center For Research Resources1996
Retinoschisis--Genetic Linkage And Positional CloningNational Eye Institute1993–1996